Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects
Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects
Authors
Herrera, Christian L.
Castillo, Wilma
Estrada, Patricia
Mancilla, Barbara
Reyes, Gerardo
Saavedra, Nicolas
Guzman Oyarzo, Neftali
Seron, Pamela
Lanas, Fernando
Salazar, Luis A.
Castillo, Wilma
Estrada, Patricia
Mancilla, Barbara
Reyes, Gerardo
Saavedra, Nicolas
Guzman Oyarzo, Neftali
Seron, Pamela
Lanas, Fernando
Salazar, Luis A.
Authors
Date
Datos de publicaciĆ³n:
ARCHIVES OF ENDOCRINOLOGY METABOLISM,Vol.60,190-198,2016
Keywords
Collections
Abstract
Objective: Metabolic syndrome (MetS) is associated with hypertension, obesity and dyslipidemia. Thus, genetic variants related with these conditions may modulate its development. We evaluated the effect of polymorphisms in the renin-angiotensin system (RAS) on metabolic syndrome risk in a cohort of Chilean subjects. Subjects and methods: A total of 152 subjects, 83 with MetS (51.2 +/- 9.6 years) and 69 without MetS (49.5 +/- 9.3 years) of both genders were included, according to the ATP III update criteria. The rs4340 Insertion/Deletion (I/D), rs699 (T>C) and rs5186 (A>C) of the ACE, AGT and AGTR1 genes, respectively, were genotyped. Results: After adjusting for age and gender, we observed the DD genotype of rs4340 associated with MetS (p = 0.02). Specifically, the DD genotype was associated with MetS risk in women (OR = 4.62, 95% CI, 1.41 - 15.04; p < 0.01). In males, the AA genotype for rs5186 variant was associated with an increased risk for developing MetS when compared with women carrying the same genotype (OR = 3.2; 95% CI, 1.03 - 9.89; p = 0.04). In subjects without MetS, DD genotype was associated with increased waist circumference (p = 0.023) while subjects with MetS carrying the rs5186 TT genotype showed higher levels of HDL-cholesterol (p = 0.031). Conclusion: The present study contributes data highlighting the role for RAS polymorphisms in predisposing to metabolic syndrome in Chilean subjects.